Cite
HARVARD Citation
Yimer, H. et al. (2022). Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study. Leukemia & lymphoma. 63 (10), pp. 2383-2392. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yimer, H. et al. (2022). Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study. Leukemia & lymphoma. 63 (10), pp. 2383-2392. [Online].